120 related articles for article (PubMed ID: 29485228)
1. Driving performance of stable outpatients with depression undergoing real-world treatment.
Miyata A; Iwamoto K; Kawano N; Aleksic B; Ando M; Ebe K; Fujita K; Yokoyama M; Akiyama T; Igarashi Y; Ozaki N
Psychiatry Clin Neurosci; 2018 Jun; 72(6):399-408. PubMed ID: 29485228
[TBL] [Abstract][Full Text] [Related]
2. Driving performance of euthymic outpatients with bipolar disorder undergoing real-world pharmacotherapy.
Yamaguchi A; Iwamoto K; Ando M; Fujita K; Yokoyama M; Akiyama T; Igarashi Y; Ozaki N
Psychiatry Clin Neurosci; 2022 May; 76(5):172-178. PubMed ID: 35037335
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers.
Sasada K; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda Y; Ozaki N
Hum Psychopharmacol; 2013 May; 28(3):281-6. PubMed ID: 23661283
[TBL] [Abstract][Full Text] [Related]
4. The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers.
Takahashi M; Iwamoto K; Kawamura Y; Nakamura Y; Ishihara R; Uchiyama Y; Ebe K; Noda A; Noda Y; Yoshida K; Iidaka T; Ozaki N
Hum Psychopharmacol; 2010 Apr; 25(3):260-7. PubMed ID: 20373478
[TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose mirtazapine on driving performance in healthy volunteers.
Iwamoto K; Kawano N; Sasada K; Kohmura K; Yamamoto M; Ebe K; Noda Y; Ozaki N
Hum Psychopharmacol; 2013 Sep; 28(5):523-8. PubMed ID: 23813948
[TBL] [Abstract][Full Text] [Related]
6. Psychomotor disturbance in depression: assessment using a driving simulator paradigm.
Bulmash EL; Moller HJ; Kayumov L; Shen J; Wang X; Shapiro CM
J Affect Disord; 2006 Jul; 93(1-3):213-8. PubMed ID: 16522332
[TBL] [Abstract][Full Text] [Related]
7. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial.
Iwamoto K; Takahashi M; Nakamura Y; Kawamura Y; Ishihara R; Uchiyama Y; Ebe K; Noda A; Noda Y; Yoshida K; Iidaka T; Ozaki N
Hum Psychopharmacol; 2008 Jul; 23(5):399-407. PubMed ID: 18383000
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission.
Daniel BD; Montali A; Gerra ML; Innamorati M; Girardi P; Pompili M; Amore M
J Psychiatr Pract; 2013 Jul; 19(4):275-87. PubMed ID: 23852102
[TBL] [Abstract][Full Text] [Related]
9. An investigation of attention, executive, and psychomotor aspects of cognitive fatigability.
Möller MC; Nygren de Boussard C; Oldenburg C; Bartfai A
J Clin Exp Neuropsychol; 2014; 36(7):716-29. PubMed ID: 24965830
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive Correlates of Young Drivers' Performance in a Driving Simulator.
Guinosso SA; Johnson SB; Schultheis MT; Graefe AC; Bishai DM
J Adolesc Health; 2016 Apr; 58(4):467-473. PubMed ID: 27013272
[TBL] [Abstract][Full Text] [Related]
12. Weight gain in depression remitted with antidepressants: pharmacological or recovery effect?
Benazzi F
Psychother Psychosom; 1998; 67(4-5):271-4. PubMed ID: 9693356
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment in remitted and non-remitted depressive patients: A follow-up comparison between first and recurrent episodes.
Roca M; López-Navarro E; Monzón S; Vives M; García-Toro M; García-Campayo J; Harrison J; Gili M
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1991-8. PubMed ID: 26293584
[TBL] [Abstract][Full Text] [Related]
14. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
15. Why do some depressed outpatients who are not in remission according to the hamilton depression rating scale nonetheless consider themselves to be in remission?
Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA
Depress Anxiety; 2012 Oct; 29(10):891-5. PubMed ID: 22887476
[TBL] [Abstract][Full Text] [Related]
16. [Driving ability with affective disorders and under psychotropic drugs].
Laux G; Brunnauer A
Nervenarzt; 2014 Jul; 85(7):822-8. PubMed ID: 24906535
[TBL] [Abstract][Full Text] [Related]
17. Determining remission from depression on two self-report symptom scales: a comparison of the Quick Inventory of Depressive Symptomatology and the Clinically Useful Depression Outcome Scale.
Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M
Compr Psychiatry; 2012 Oct; 53(7):1034-8. PubMed ID: 22520091
[TBL] [Abstract][Full Text] [Related]
18. Excessive daytime sleepiness and on-road driving performance in patients with Parkinson's disease.
Amick MM; D'Abreu A; Moro-de-Casillas ML; Chou KL; Ott BR
J Neurol Sci; 2007 Jan; 252(1):13-5. PubMed ID: 17109893
[TBL] [Abstract][Full Text] [Related]
19. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?
Zimmerman M; Martinez JA; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M
J Clin Psychiatry; 2012 Jun; 73(6):790-5. PubMed ID: 22569085
[TBL] [Abstract][Full Text] [Related]
20. Effects of oxcarbazepine and carbamazepine on driving ability: a double-blind, randomized crossover trial with healthy volunteers.
Kaussner Y; Kenntner-Mabiala R; Hoffmann S; Klatt J; Tracik F; Krüger HP
Psychopharmacology (Berl); 2010 May; 210(1):53-63. PubMed ID: 20237772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
